公开(公告)号：US11723885B2

公开(公告)日：2023-08-15

申请号：US17521581

申请日：2021-11-08

申请人： Acura Pharmaceuticals, Inc.

发明人： Ronald L. Leech, Jr.

IPC分类号： A61K31/137 ,  A61K9/20 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/32 ,  A61K47/38

CPC分类号： A61K31/137 ,  A61K9/2013 ,  A61K9/2027 ,  A61K9/2031 ,  A61K9/2054 ,  A61K9/2059 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/32 ,  A61K47/38

摘要： Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.

公开(公告)号：US11197837B2

公开(公告)日：2021-12-14

申请号：US16803474

申请日：2020-02-27

申请人： ACURA PHARMACEUTICALS, INC.

发明人： Ronald L. Leech, Jr.

IPC分类号： A61K31/137 ,  A61K9/20 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/32 ,  A61K47/38

摘要： Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.

公开(公告)号：US10004699B2

公开(公告)日：2018-06-26

申请号：US14734364

申请日：2015-06-09

申请人： Acura Pharmaceuticals, Inc.

发明人： Ronald L. Leech, Jr.

IPC分类号： A61K31/137 ,  A61K9/20 ,  A61K47/10 ,  A61K47/14 ,  A61K47/12 ,  A61K47/32 ,  A61K47/38

CPC分类号： A61K31/137 ,  A61K9/2013 ,  A61K9/2027 ,  A61K9/2031 ,  A61K9/2054 ,  A61K9/2059 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/32 ,  A61K47/38

摘要： Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.